Cargando…
Safety and feasibility of using acellular sterile filtered amniotic fluid as a treatment for patients with COVID-19: protocol for a randomised, double-blinded, placebo-controlled clinical trial
INTRODUCTION: Human amniotic fluid (hAF) has been shown to reduce inflammation in multiple experimental models. hAF has previously been approved by the US Food and Drug Administration (FDA) as a human cellular and tissue product for tissue injury for human administration, and used safely in thousand...
Autores principales: | Tonna, Joseph E, Pierce, Jan, Hatton, Nathan, Lewis, Giavonni, Phillips, John D, Messina, Alyssa, Skidmore, Chloe R, Taylor, Kirsten, Selzman, Craig H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880092/ https://www.ncbi.nlm.nih.gov/pubmed/33574155 http://dx.doi.org/10.1136/bmjopen-2020-045162 |
Ejemplares similares
-
A pilot trial of human amniotic fluid for the treatment of COVID-19
por: Selzman, Craig H., et al.
Publicado: (2021) -
Inhaled amikacin versus placebo to prevent ventilator-associated pneumonia: the AMIKINHAL double-blind multicentre randomised controlled trial protocol
por: Tavernier, Elsa, et al.
Publicado: (2021) -
Dexmedetomidine after Cardiac Surgery for Prevention of Delirium (EXACTUM) trial protocol: a multicentre randomised, double-blind, placebo-controlled trial
por: Gargadennec, Thomas, et al.
Publicado: (2022) -
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol
por: Kotsaki, Antigone, et al.
Publicado: (2022) -
Adjuvant Lipoic acid Injection in Sepsis treatment in China (ALIS study): protocol for a randomised, single-blind, placebo-controlled trial
por: Hu, Linhui, et al.
Publicado: (2023)